A study of shatpushpa arka in infantile colic at age of day 1 to 3 months

A single arm clinical study to evaluate the efficacy of shatpushpa arka in infantile colic at the age of day 1-3 months

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054335

Enrollment

Registered

2023-06-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Full term healthy neonates Babies suffering from definitive symptoms of Infantile Colic Babies whose parents are ready to participate in the clinical trial by giving informed written consent

Exclusion criteria

Exclusion criteria: Patients who require surgical management Patients associated with symptoms like vomiting diarrhea fever or any other pathology Patients with congenital anomalies Patients with unstable vitals

Design outcomes

Primary

Measure	Time frame
To Reduce The Episodes Of Infantile ColicTimepoint: Third Day And Fifth Day	—

Secondary

Measure	Time frame
To Reduce The Irritability Due To Infantile ColicTimepoint: Shatpushpa Arka Will Be Given On 0th,5th And 7th Day Follow Ups Will Be On 5th And 7th Day Total Duration Of Study Will Be 5 Days	—

Countries

India

Contacts

Public ContactDr Sandeep Daberao

DR DY PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE PIMPRI PUNE

dr.deep901@gmail.com9545402018

Outcome results